A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)

Trial Profile

A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs T 89 (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Sponsors Tasly Pharmaceuticals, Inc.
  • Most Recent Events

    • 20 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 May 2017.
    • 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top